07-Nov-2026 12:20:12
ASTRAZENECA : TO LAUNCH DATVERZO IN INDIA
• AstraZeneca Pharma India to launch Datopotamab Deruxtecan (brand name Datverzo) in India in November 2026 • Company had received Import and Market Permission…
Latest market headlines for ASTRAZEN on Terminal.
07-Nov-2026 12:20:12
• AstraZeneca Pharma India to launch Datopotamab Deruxtecan (brand name Datverzo) in India in November 2026 • Company had received Import and Market Permission…
05-Nov-2026 19:37:44
ONCOLOGY Q2 REVENUE UP 27.83% AT ₹508.50 CR (YOY) BIOPHARMACEUTICALS Q2 REVENUE UP 26.97% AT ₹161.00 CR (YOY) RARE DISEASES Q2 REVENUE UP 436.84% AT ₹20.40 CR…
05-Nov-2026 17:39:48
REVENUE UP 30.41% AT ₹729.10 CR (YOY), UP 6.78% (QOQ) EBITDA UP 27.12% AT ₹95.57 CR (YOY), UP 95.28% (QOQ) MARGINS AT 13.11% VS 13.45% (YOY), 7.17% (QOQ)
02-Nov-2026 11:52:59
• Delhi High Court order dated October 29, 2026 directs NPPA not to take coercive steps until next hearing on January 11, 2027 • NPPA notice alleged overchargi…
16-Oct-2026 19:09:29
• New corporate office inaugurated in Mumbai, spread across 25,600 sq ft • India becomes one of AstraZeneca's largest and most diverse global footprints, suppo…
18-Sept-2026 16:57:49
ASTRAZENECA : FACES PENALTY OF RS 1.88 LAKH FROM ROC
13-Jun-2026 12:40:13
• Mr. Alok Nath has resigned as Director, Key Managerial Personnel, and Senior Management Personnel.
12-Jun-2026 19:06:12
• 🇮🇳 AstraZeneca Pharma India receives CDSCO approval to import and market Enhertu (Trastuzumab Deruxtecan) 100 mg/5 mL • 🎯 Approval granted for an addition…